United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded Apr 6, 2026 · Filed Apr 7, 2026

On Apr 6, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$558.40 for US$5.58M under a trading plan, leaving 18,876 shares. Filed Apr 7, 2026 (Form 4).

Sold
10,000 shares
Price
US$558.40 average (US$552.78 to US$566.01)
Value
US$5.58M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 6, 2026Common StockOption exercise10,000US$135.4228,876Direct
Apr 6, 2026Common StockSale120US$552.7828,756Direct
Apr 6, 2026Common StockSale437US$553.9728,319Direct
Apr 6, 2026Common StockSale1,158US$555.2127,161Direct
Apr 6, 2026Common StockSale1,205US$556.0625,956Direct
Apr 6, 2026Common StockSale1,840US$557.1924,116Direct
Apr 6, 2026Common StockSale1,679US$558.3122,437Direct
Apr 6, 2026Common StockSale860US$559.4721,577Direct
Apr 6, 2026Common StockSale616US$560.1820,961Direct
Apr 6, 2026Common StockSale645US$561.5620,316Direct
Apr 6, 2026Common StockSale619US$562.7519,697Direct
Apr 6, 2026Common StockSale539US$563.4719,158Direct
Apr 6, 2026Common StockSale82US$564.4319,076Direct
Apr 6, 2026Common StockSale200US$566.0118,876Direct

Source

View original at SEC

Related